We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Quantitative human biomonitoring of micro- and nanoplastics: Exposure profiles, mechanistic insights, and health implications
Summary
Researchers conducted a comprehensive analysis of 70 studies that measured micro- and nanoplastics in human body samples collected between 2019 and 2025. They found plastic particles present across multiple organ systems and body fluids, with polyethylene, polypropylene, and polystyrene being the most commonly detected types. While evidence indicates potential associations with oxidative stress and inflammation, the study notes that differences in measurement methods across labs make it difficult to directly compare results, and no causal health relationships have been firmly established yet.
Micro- and nanoplastic (MnP) pollution has become an escalating environmental and public health concern, supported by increasing human biomonitoring evidence of their presence in the body. We performed a PRISMA-guided quantitative analysis of 70 human-sample studies (2019-2025) spanning multiple organ systems and body fluids. After being standardized by the unit, reported concentrations ranged 0.2-342.55 items/g or 0.43-275.78 μg/g, with relatively higher content in digestive, reproductive, circulatory, and respiratory samples. Polyethylene (PE, n = 84), polypropylene (PP, n = 63), polystyrene (PS, n = 59), polyethylene terephthalate (PET), and polyvinyl chloride (PVC) were predominant, less frequent polymers followed a long-tail distribution. Particle sizes clustered at 10-100 μm, and nanoplastics (<1 μm) were infrequently quantified due to analytical limits, a few studies have reported detections in placental or brain tissues, but these observations remain preliminary and require prudent interpretation. Common digestion protocols included 30 % HO and 10 % KOH. μ-Raman, LDIR, μ-FTIR, and Py-GC/MS produced systematic differences between particle-count and mass-based metrics, underscoring methodological dependence that limits interstudy comparability. Current toxicological evidence and limited epidemiological observations indicate potential associations with oxidative stress, inflammation, immune alterations, and endocrine-related effects, while no causal relationships have been demonstrated in humans. However, prevalence estimates and risk assessments are limited by small sample sizes and uneven age and sex representation. Importantly, this quantitative synthesis of human-sample data integrates multi-matrix MnP concentrations, delineates exposure profiles, identifies critical knowledge gaps, and underscores the need for standardized analytical approaches and longitudinal low-dose studies to support health risk assessment and policy development.
Sign in to start a discussion.
More Papers Like This
Microplastics in Humans: A Critical Review of Biomonitoring Evidence and Immune–Metabolic Associations
This review critically evaluates the current evidence on microplastic detection in human tissues and biological fluids, focusing on methodological challenges and the potential biological mechanisms of action. Researchers found significant variation across studies due to differences in analytical techniques and sample handling protocols. The study highlights emerging evidence linking microplastic presence in the body to immune and metabolic disruptions, while noting that standardized detection methods are urgently needed.
Human biomonitoring of microplastics and health implications: A review
This review compiles 91 studies showing that microplastics have been detected in human blood, urine, stool, lung tissue, breast milk, semen, and placenta, confirming widespread human exposure. While our bodies have some ability to clear these particles, microplastics that accumulate in tissues may trigger inflammation, oxidative stress, gut disruption, and reproductive problems. The authors stress that more standardized monitoring methods are needed to fully understand the health consequences.
Microplastics and Human Health: A Comprehensive Review on Exposure Pathways, Toxicity, and Emerging Risks
This comprehensive review examines microplastic exposure pathways in humans, methods of detection, and the potential toxic effects on various biological systems. The study highlights growing evidence that microplastics can enter the body through ingestion, inhalation, and dermal contact, and may affect multiple organ systems, though significant uncertainties remain about long-term health outcomes.
Why Detecting Nanoplastics in Humans Matters: Exposure Routes, Biological Evidence, and Potential Health Implications
This review summarizes current evidence on nanoplastic detection in human biological samples, including blood, lung tissue, placenta, and brain samples, confirming that human exposure involves internal uptake rather than just environmental contact. The study discusses how ingestion and inhalation are the dominant exposure pathways, while experimental research suggests nanoplastics may induce oxidative stress, inflammation, and endocrine disruption, though direct causal links in humans remain limited.
[Research Progress on Characteristics of Human Microplastic Pollution and Health Risks].
This review summarizes current knowledge about microplastic contamination in the human body, finding that particles smaller than 50 micrometers are most commonly detected, with polyethylene, polypropylene, and PET being the dominant types. Evidence indicates that microplastics enter humans mainly through food, water, and air, and may contribute to inflammation, oxidative stress, and disruption of gut bacteria.